TC
WVE icon

Truvestments Capital’s Wave Life Sciences WVE Stock Holding History

Truvestments Capital’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$330 Hold
57
– – ﹤0.01% 1086
2026
Q1 		$412 Hold
57
– – ﹤0.01% 1097
2025
Q4 		$966 Buy
57
+55
+2,750% +$559 ﹤0.01% 922
2025
Q3 		$13 Hold
2
– – ﹤0.01% 1038
2025
Q2 		$12 Buy
+2
New +$13 ﹤0.01% 973

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Truvestments Capital's WVE Position: Q2 2026 in Review

Truvestments Capital held its Wave Life Sciences (WVE) position steady in Q2 2026 at 57 shares worth $330. The position accounts for ﹤0.01% of the portfolio, ranked #1086.

Truvestments Capital first reported a position in WVE in Q2 2025 and has held it in 5 quarters since. The position peaked at $966 in Q4 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Truvestments Capital held 57 shares of Wave Life Sciences worth $330 as of Q2 2026.
  • Truvestments Capital left its Wave Life Sciences share count unchanged in Q2 2026.
  • Wave Life Sciences made up ﹤0.01% of Truvestments Capital's portfolio in Q2 2026, its #1086 holding.
  • Truvestments Capital first reported a position in Wave Life Sciences in Q2 2025 and has held it in 5 quarters since.
  • Truvestments Capital's Wave Life Sciences position peaked at $966 in Q4 2025.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Truvestments Capital's 13F filing for Q2 2026, filed 12 Aug 2026.